FDA Approves Susvimo for Diabetic Macular Edema
2025-02-05
Approval marks the first and only continuous delivery treatment as an alternate to regular eye injectionsContinue Reading
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
2025-02-05
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
Many Americans Misguided On Daily Aspirin, Survey Finds
2025-02-04
TUESDAY, Feb. 4, 2025 (HealthDay News) — Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has found. Nearly half (48%) of people incorrectly think that the benefits of taking low-dose aspirin daily to reduceContinue Reading
Heart Patients Aren’t Taking Lifesaving Meds
2025-02-04
TUESDAY, Feb. 4, 2025 (HealthDay News) — Drugs like blood thinners, cholesterol-lowering statins and blood pressure meds can protect the health and extend the lives of people with heart disease. But only if patients take the drugs — and many around the world aren’t, a new study says. Overall, fewerContinue Reading
FDA Approves First New Non-Opioid Pain Pill in Decades
2025-01-31
FRIDAY, Jan. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgeryContinue Reading
Daily Aspirin Reduces Colon Cancer Risk: Study
2025-01-29
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutationContinue Reading
COVID-19 Remains Major Health Threat in U.S.
2025-01-29
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — COVID-19 continues to be a threat to America’s health, causing more illness and death than either influenza or respiratory syncytial virus (RSV), a new study suggests. COVID accounted for 3 of 5 (60%) respiratory illnesses among military veterans treated by the U.S. VeteransContinue Reading
COVID Vaccine Hesitancy Reducing Childhood Vaccinations
2025-01-24
FRIDAY, Jan. 24, 2025 (HealthDay News) — Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children. Young children of parents who declined the COVID vaccine are about 25% less likely to get the standard measles/mumps/rubella (MMR) vaccine, researchers reported in a new studyContinue Reading
Medical Weed Users At Risk for Addiction
2025-01-24
FRIDAY, Jan. 24, 2025 (HealthDay News) — People using weed for medical purposes are as likely – or more – to become addicted to cannabis as recreational tokers, a new study says. Folks using medical marijuana were more likely to have cannabis use disorder than those who get high recreationally,Continue Reading
FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
2025-01-23
Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicinesContinue Reading
-690x550.jpg)
Controlling Infections Might Lower Dementia Risk
2025-01-23
THURSDAY, Jan. 23, 2025 (HealthDay News) — Preventing or treating infections could be a key means of warding off dementia, a new evidence review says. Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Jan. 21 inContinue Reading
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
2025-01-22
Drug is the first and only approved monotherapy for refractory major depressive disorderContinue Reading
Trump Ends Push To Slash Prescription Drug Costs
2025-01-22
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid. Trump’s order, signed shortly after his inauguration on Monday, targets policies his administrations calls “deeplyContinue Reading
Moderna Receives $590M From HHS To Develop Bird Flu Vaccine
2025-01-21
TUESDAY, Jan. 21, 2025 (HealthDay News) — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This funding, announced Friday by Moderna, builds on the $176 million it received from HHS lastContinue Reading